Breaking news: New 3D study in Radiology Read Evidence
We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.
CE marked and FDA cleared
With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara® provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us
NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU
Begin patient treatment earlier to improve survival rates
With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs
Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis
Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.
Client undergoes mammogram
Transpara analyses mammogram scan
Radiologist reads with support from Transpara, increasing confidence in decision
Make more accurate and consistent decision
Accuracy.
Workload Reduction.
Risk.
Internationally renowned breast radiologist, Dr Rachel Brem, Professor of Radiology at The George Washington University School of Medicine and Health
Read moreMore peer reviewed evidence demonstrates that Transpara not only improves Radiologists’ accuracy but also helps to speed up reading time
Read moreRead about how Transpara helps reduce radiologist’s workload by up to 70% for BOTH 2D and 3D mammography in this
Read moreNatasja Janssen, Clinical Scientist ScreenPoint Medical has a clear and compelling mission to help radiologists detect breast cancer as early
Read moreHere’s an interesting article from the Dutch Ministry of Foreign Affairs entitled “AI breast cancer diagnoses may reduce disparity in
Read moreProfessor Nico Karssemeijer and Professor Sir Michael Brady formed ScreenPoint Medical seven years ago with the aim of reducing the
Read more
